₹82.95
▲ +5.74 +7.43%
29 Jul 2026
BSE Listed
Astal Laboratories Limited (512600)
Volume: 17,115Avg Vol 1W: 11,742Avg Vol 1M: 16,87152W Range:₹60.45₹103.2
Key Ratios
Checked just nowMarket Cap₹363 Cr
Current Price₹82.95
Previous Close₹77.21
High / Low (52w)₹103.2 / ₹60.45
Volume17,115
Avg Vol (1W)11,742
Avg Vol (1M)16,871
Stock P/E24.69
Book Value₹77.65
Dividend Yield0%
ROE440.72%
ROA246.63%
Revenue (TTM)—
Revenue Growth—
Profit Margin0%
Total Debt—
Shares Outstanding4 Cr
Face Value—
EPS (TTM)₹3.36
P/B1.07
Debt / Equity0.23
50 DMA₹79.08
200 DMA₹81.26
Day change+7.43%
Price Chart
₹82.95▼ 9.97% · 1Y
2025-07-292026-07-29
20-day avg volume: 15K shares
Pros
- Healthy return on equity of 440.7%.
- Company is almost debt-free.
Cons
- Revenue fell 22% YoY.
Quarterly Results
| Metric | Mar 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|
| Revenue | ₹23 Cr | ₹52 Cr | ₹134 Cr |
| EBITDA | ₹4 Cr | ₹3 Cr | ₹9 Cr |
| Net Profit | ₹3 Cr | ₹2 Cr | ₹8 Cr |
| EPS | — | — | — |
Profit & Loss (Annual)
| Metric | Sept 2024 | Dec 2024 | Mar 2025 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹13 Cr | ₹14 Cr | ₹23 Cr | ₹64 Cr | ₹25 Cr | ₹38 Cr | ₹52 Cr | ₹41 Cr |
| EBITDA | ₹3 Cr | ₹3 Cr | ₹4 Cr | ₹13 Cr | ₹3 Cr | ₹4 Cr | ₹3 Cr | ₹2 Cr |
| Net Profit | ₹2 Cr | ₹2 Cr | ₹3 Cr | ₹9 Cr | ₹2 Cr | ₹3 Cr | ₹2 Cr | ₹1 Cr |
| EPS | — | — | — | 8.04 | — | — | — | — |
Balance Sheet
| Metric | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | ₹5 Cr | ₹5 Cr | ₹5 Cr | ₹5 Cr | ₹5 Cr | ₹10 Cr | ₹37 Cr | ₹63 Cr |
| Total Liabilities | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹5 Cr | ₹13 Cr | ₹27 Cr |
| Equity | ₹5 Cr | ₹5 Cr | ₹5 Cr | ₹5 Cr | ₹5 Cr | ₹5 Cr | ₹23 Cr | ₹36 Cr |
| Total Debt | — | — | — | — | — | — | — | — |
Cash Flow
| Metric | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|
| Operating | ₹0 Cr | ₹0 Cr | ₹-1 Cr | ₹-6 Cr | ₹-12 Cr |
| Investing | ₹0 Cr | ₹0 Cr | ₹2 Cr | ₹-6 Cr | ₹-8 Cr |
| Financing | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹18 Cr | ₹3 Cr |
| Free Cash Flow | ₹0 Cr | ₹0 Cr | ₹-1 Cr | ₹-11 Cr | ₹-12 Cr |
Shareholding
Promoter 4.53% Institutions 0% Public 95.47%
Efficiency & Working Capital
ROCE5.2%
Interest Coverage18.1
Dividend Payout—
Debtor Days—
Inventory Days—
Payable Days—
Cash Conversion Cycle—
Working Capital Days—
Shareholding Details
As of 2026-06-30
Promoter4.5%
FII0%
DII0%
Institutions0%
Public95.5%
Promoter Pledge0%
No. of Shareholders3,274
Shareholding Pattern
Quarterly — figures in %. Latest 12 quarters.
| Period | Mar 2024 | Jun 2024 | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Aug 2025 | Sept 2025 | Dec 2025 | Mar 2026 | May 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Promoters | 19.9% | 19.9% | 19.9% | 19.9% | 19.9% | 19.9% | 18.2% | 18.2% | 18.2% | 4.7% | 4.5% | 4.5% |
| FIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| DIIs | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 80.1% | 80.1% | 80.1% | 80.1% | 80.1% | 80.1% | 81.8% | 81.8% | 81.8% | 95.3% | 95.5% | 95.5% |
| Promoter Pledge | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| No. of Shareholders | 1,241 | 1,242 | 1,629 | 1,925 | 2,302 | 2,721 | 2,950 | 2,899 | 2,926 | 3,065 | 3,314 | 3,274 |
Returns History (ROE / ROCE / ROA)
| Period | ROE | ROCE | ROA | P/E |
|---|---|---|---|---|
| 202503 | — | — | — | — |
Major Shareholders (>1%)
| Name | Category | Stake | Shares |
|---|---|---|---|
| Sesha Sai Nikhil Chintalapati | Public Shareholding | 11.4% | 49,85,278 |
| Suryanarayana Raju Rudraraju . | Public Shareholding | 6.8% | 29,55,833 |
| Kommera Harish | Public Shareholding | 6.4% | 28,15,623 |
| Amit Mishra | Public Shareholding | 4.6% | 20,00,000 |
| Aceso Research Labs Llp | Shareholding of Promoter and Promoter Group | 4.5% | 19,85,595 |
| Abraham George | Public Shareholding | 4.4% | 19,26,999 |
| Liju Mathew | Public Shareholding | 3.8% | 16,66,666 |
| Pavani Vupparapalli | Public Shareholding | 3.8% | 16,50,000 |
| Venkataramana Reddy Mallela | Public Shareholding | 2.9% | 12,50,000 |
| Pradeepkumar M G | Public Shareholding | 2.7% | 11,60,000 |
| Doradla Radha Krishna | Public Shareholding | 2.6% | 11,25,370 |
| K S Srinivas Rao | Public Shareholding | 1.9% | 8,33,333 |
| Kunapareddy Bala Gopala Krishna Rao . | Public Shareholding | 1.3% | 5,62,500 |
| Nitin Gupta | Public Shareholding | 1.1% | 5,00,000 |
Board of Directors
| Name | Designation | Year |
|---|---|---|
| Ravikanti Shailaja | Independent Non Exe. Director | 2025 |
| MAGGIDI VENKATESH | Non Executive Director | 2025 |
| Hemachakrapani Bangaraiahgari | Independent Director | 2025 |
| Sudheer Karna Kankanala | Whole-time Director | 2025 |
| P. Radha Kishore | Independent Director | 2025 |
| Birendra Kumar Sahoo | Independent Director | 2025 |
| Julius Paul Reinhard Paschke | Independent Director | 2025 |
| Mahendra Kumar | Company Sec. & Compli. Officer | 2025 |
Capital Structure (₹ Cr)
| Year | Face Value | Authorised | Issued | Paid-up |
|---|---|---|---|---|
| 2025 | ₹10 | 20 | 10 | 10 |
Related-Party Transactions (₹ Cr)
| Year | Subsidiaries | Associates | JV | KMP | Others | Total |
|---|---|---|---|---|---|---|
| 2025 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 | 0 |
| 2025 | 0 | 0 | 0 | 0 | 0 | 0 |
Insider / Designated-Person Trades
1 recent disclosure(s)
ACESO RESEARCH LABS LLPAcquisition · 21,007
Substantial Acquisitions (SAST)
8 disclosure(s)
Pref. Allotment14/01/2026 · —
Pref. Allotment14/01/2026 · 48,67,348
Pref. Allotment14/01/2026 · —
Pref. Allotment14/01/2026 · 17,50,000
Pref. Allotment14/01/2026 · 29,56,666
Pref. Allotment14/01/2026 · 48,67,348
Company Information
🌐 www.miel.co.in ↗
📍 House No 4-50/1 Sy No 134 132, Block B 8th Floor Flat No 801, Hyderabad, Telangana, 500032
Technical AnalysisPremium
Technical analysis (Premium)
Log in to see RSI, MACD, moving averages, oscillators and pivot levels for this stock.
More stocks
Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search